JOHN PAPPAJOHN Insider Trading $CGIX Vyant Bio, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for JOHN PAPPAJOHN.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of JOHN PAPPAJOHN. JOHN PAPPAJOHN is 10% Owner in HOOPER HOLMES INC ($HH) and Director in CAREGUIDE INC ($PATY) and Director in MYnd Analytics, Inc. ($CNSO) and Acting Chief Executive Officer in American CareSource Holdings, Inc. ($GNOW) and CEO and Chairman in American CareSource Holdings, Inc. ($GNOW) and Director in American CareSource Holdings, Inc. ($GNOW) and Director in CANCER GENETICS, INC ($CGIX) and President in Kura Oncology, Inc. ($KURA).

JOHN PAPPAJOHN in Vyant Bio, Inc.

Trading Symbol: CGIX
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of JOHN PAPPAJOHN: Director
Holdings: 4,781,204 shares
Current Value: $11,474,890
Latest Transaction: Feb 01 2019
$CGIX Market Capitalization: $42.50M
$CGIX Previous Close: $2.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of JOHN PAPPAJOHN in Vyant Bio, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, GNOW, PATY, MYND, HH, KURA, CGIX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Feb 01 2019	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	0.23	1,000,000	230,000	4,781,204	3.8 M to 4.8 M (+26.45 %)
Jan 16 2019	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	0.23	1,000,000	225,000	3,781,204	2.8 M to 3.8 M (+35.96 %)
Jan 16 2019	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	0.23	1,000,000	225,000	3,781,204	2.8 M to 3.8 M (+35.96 %)
Dec 11 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	1.86	150,000	279,000	2,781,204	2.6 M to 2.8 M (+5.70 %)
Oct 02 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Option Exercise	A	2.75	5,000	13,750	5,000
Oct 02 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Grant	A	0.00	2,500	0	2,631,204	2.6 M to 2.6 M (+0.10 %)
Aug 18 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	3.28	20,000	65,560	2,628,704	2.6 M to 2.6 M (+0.77 %)
Aug 18 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	3.24	66,185	214,108	2,608,704	2.5 M to 2.6 M (+2.60 %)
Jun 12 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	3.75	100,000	374,870	2,542,519	2.4 M to 2.5 M (+4.09 %)
Jun 08 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Option Exercise	A	4.15	10,000	41,500	10,000
Jun 08 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Grant	A	0.00	2,500	0	2,442,519	2.4 M to 2.4 M (+0.10 %)
May 17 2017	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	3.80	19,310	73,318	2,440,019	2.4 M to 2.4 M (+0.80 %)
Nov 29 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	1.45	100,000	145,280	2,420,709	2.3 M to 2.4 M (+4.31 %)
Nov 16 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	1.48	31,100	46,050	2,320,709	2.3 M to 2.3 M (+1.36 %)
Oct 13 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Option Exercise	A	1.81	10,000	18,100	10,000
Oct 13 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Grant	A	0.00	2,500	0	2,289,609	2.3 M to 2.3 M (+0.11 %)
Aug 17 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	2.29	45,000	103,203	2,287,109	2.2 M to 2.3 M (+2.01 %)
Aug 16 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	2.20	79,722	175,636	2,242,109	2.2 M to 2.2 M (+3.69 %)
Aug 16 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	2.10	67,778	142,652	2,162,387	2.1 M to 2.2 M (+3.24 %)
May 26 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Option Exercise	P	2.25	158,910	357,548	158,910
May 26 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	0.00	317,820	0	2,099,609	1.8 M to 2.1 M (+17.84 %)
Mar 17 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	2.64	50,000	132,060	1,771,789	1.7 M to 1.8 M (+2.90 %)
Mar 16 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	2.62	10,579	27,734	1,721,789	1.7 M to 1.7 M (+0.62 %)
Mar 16 2016	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	2.52	89,421	225,144	1,711,210	1.6 M to 1.7 M (+5.51 %)
Nov 16 2015	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Option Exercise	P	5.00	100,000	500,000	100,000
Nov 16 2015	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	0.00	100,000	0	1,621,789	1.5 M to 1.6 M (+6.57 %)
Oct 16 2015	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Option Exercise	A	7.80	10,000	78,000	10,000
Oct 16 2015	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Grant	A	0.00	2,500	0	1,521,789	1.5 M to 1.5 M (+0.16 %)
Aug 27 2015	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	10.25	2,500	25,624	1,519,289	1.5 M to 1.5 M (+0.16 %)
Aug 27 2015	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	8.97	2,500	22,436	1,516,789	1.5 M to 1.5 M (+0.17 %)
May 18 2015	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	10.74	5,000	53,700	1,519,289	1.5 M to 1.5 M (+0.33 %)
Mar 18 2015	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	7.15	15,000	107,237	1,514,289	1.5 M to 1.5 M (+1.00 %)
Mar 18 2015	CGIX	CANCER GENETICS, I ...	PAPPAJOHN JOHN	Director	Buy	P	7.45	35,000	260,586	1,499,289	1.5 M to 1.5 M (+2.39 %)

Page: 1